Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.

Literature DB >> 16495278

Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.

Hua Quan¹, Ying-Ying Cao, Zheng Xu, Jing-Xia Zhao, Ping-Hui Gao, Xiao-Feng Qin, Yuan-Ying Jiang.

Abstract

In vitro interaction of fluconazole and berberine chloride was investigated against 40 fluconazole-resistant clinical isolates of Candida albicans. Synergism in fungistatic activity was found with the checkerboard microdilution assay. The findings of agar diffusion tests and time-kill curves confirmed the synergistic interaction, but no antagonistic action was observed.

Entities: Chemical Species

Mesh：

Substances：

Year: 2006 PMID： 16495278 PMCID： PMC1426442 DOI： 10.1128/AAC.50.3.1096-1099.2006

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

27 in total

Review 1. Rationale for combination antifungal therapy.

Authors: R E Lewis; D P Kontoyiannis
Journal: Pharmacotherapy Date: 2001-08 Impact factor: 4.705

2. Synergy, antagonism, and what the chequerboard puts between them.

Authors: F C Odds
Journal: J Antimicrob Chemother Date: 2003-06-12 Impact factor: 5.790

3. Synergistic effect of ofloxacin and fluconazole against azole-resistant Candida albicans.

Authors: E Sasaki; S Maesaki; Y Miyazaki; K Yanagihara; K Tomono; T Tashiro; S Kohno
Journal: J Infect Chemother Date: 2000-09 Impact factor: 2.211

4. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.

Authors: S Perea; J L López-Ribot; W R Kirkpatrick; R K McAtee; R A Santillán; M Martínez; D Calabrese; D Sanglard; T F Patterson
Journal: Antimicrob Agents Chemother Date: 2001-10 Impact factor: 5.191

5. In vitro activity of propyl gallate-azole drug combination against fluconazole- and itraconazole-resistant Candida albicans strains.

Authors: F D D'Auria; M Tecca; R Strippoli; N Simonetti
Journal: Lett Appl Microbiol Date: 2001-04 Impact factor: 2.858

6. Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans.

Authors: O Marchetti; P Moreillon; M P Glauser; J Bille; D Sanglard
Journal: Antimicrob Agents Chemother Date: 2000-09 Impact factor: 5.191

Review 7. Molecular basis of resistance to azole antifungals.

Authors: Antonella Lupetti; Romano Danesi; Mario Campa; Mario Del Tacca; Steven Kelly
Journal: Trends Mol Med Date: 2002-02 Impact factor: 11.951

8. The direct cost and incidence of systemic fungal infections.

Authors: Leslie S Wilson; Carolina M Reyes; Michelle Stolpman; Julie Speckman; Karoline Allen; Johnny Beney
Journal: Value Health Date: 2002 Jan-Feb Impact factor: 5.725

9. Berberine synergy with amphotericin B against disseminated candidiasis in mice.

Authors: Yongmoon Han; Jue-Hee Lee
Journal: Biol Pharm Bull Date: 2005-03 Impact factor: 2.233

10. Antifungal activity of Mahonia aquifolium extract and its major protoberberine alkaloids.

Authors: Anna Volleková; Daniela Kost'álová; Viktor Kettmann; Jaroslav Tóth
Journal: Phytother Res Date: 2003-08 Impact factor: 5.878

48 in total

1. In Vitro Activity of Berberine Alone and in Combination with Antifungal Drugs Against Planktonic Forms and Biofilms of Trichosporon Asahii.

Authors: Lin Cong; Yong Liao; Suteng Yang; Rongya Yang
Journal: Mycopathologia Date: 2017-01-31 Impact factor: 2.574

Review 2. Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans.

Authors: Jinhui Cui; Biao Ren; Yaojun Tong; Huanqin Dai; Lixin Zhang
Journal: Virulence Date: 2015 Impact factor: 5.882

3. In vitro interaction between fluconazole and triclosan against clinical isolates of fluconazole-resistant Candida albicans determined by different methods.

Authors: Lu Yu; Guanghui Ling; Xuming Deng; Jing Jin; Qi Jin; Na Guo
Journal: Antimicrob Agents Chemother Date: 2011-05-16 Impact factor: 5.191

4. Azole-synergistic anti-candidal activity of altenusin, a biphenyl metabolite of the endophytic fungus Alternaria alternata isolated from Terminalia chebula Retz.

Authors: Jatuporn Phaopongthai; Suthep Wiyakrutta; Duangdeun Meksuriyen; Nongluksna Sriubolmas; Khanit Suwanborirux
Journal: J Microbiol Date: 2013-12-19 Impact factor: 3.422